Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
HUTSON, Thomas E, DAVIS, Ian D, PANDITE, Lini, FIGLIN, Robert A, MACHIELS, Jean-Pascal H, DE SOUZA, Paul L, ROTTEY, Sylvie, HONG, Bao-Fa, EPSTEIN, Richard J, BAKER, Katherine L, MCCANN, Lauren, CROFTS, Theresa
Published in Journal of clinical oncology (20.01.2010)
Published in Journal of clinical oncology (20.01.2010)
Get full text
Journal Article
Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study
GOLDSTEIN, David, BENNETT, Barbara K, MCCOURT, Junie, FRIEDLANDER, Michael, HICKIE, Ian B, LLOYD, Andrew R, WEBBER, Kate, BOYLE, Fran, DE SOUZA, Paul L, WILCKEN, Nicholas R. C, SCOTT, Elizabeth M, TOPPLER, Ruth, MURIE, Penelope, O'MALLEY, Linda
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
RESIRT: A Phase 1 Study of Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres in Patients With Primary Renal Cell Carcinoma
de Souza, Paul L, Aslan, Peter, Clark, William, Nour, Ramy, de Silva, Suresh
Published in Clinical genitourinary cancer (01.10.2022)
Published in Clinical genitourinary cancer (01.10.2022)
Get full text
Journal Article
Randomized Crossover Study Evaluating the Effect of Gemcitabine Infusion Dose Rate: Evidence of Auto-Induction of Gemcitabine Accumulation
Grimison, Peter, Galettis, Peter, Manners, Susan, Jelinek, Maria, Metharom, Ekkaphon, de Souza, Paul L, Liauw, Winston, Links, Matthew J
Published in Journal of clinical oncology (20.12.2007)
Published in Journal of clinical oncology (20.12.2007)
Get full text
Journal Article
MP16-12 SELECTIVE INTERNAL RADIATION THERAPY (SIRT) WITH YTTRIUM-90 (Y-90) RESIN MICROSPHERES IN PATIENTS WITH PRIMARY RENAL CELL CARCINOMA (RCC): IMPACT ON RENAL FUNCTION AND QUALITY OF LIFE IN THE RESIRT STUDY
Aslan, Peter, Clark, William, Patel, Manish, Vass, Justin, Cade, David N, de Silva, Suresh Janeendra, de Souza, Paul L
Published in The Journal of urology (01.04.2017)
Published in The Journal of urology (01.04.2017)
Get full text
Journal Article
Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer
De Souza, Paul L, Russell, Pamela J, Kearsley, John H, Howes, Laurence G
Published in Nutrition reviews (01.09.2010)
Published in Nutrition reviews (01.09.2010)
Get full text
Journal Article
Functionalization of microspheres with malonates using Michael Addition as a pathway to create a drug delivery system for platinum drugs for the treatment of liver cancer
Gu, Wenfang, Gaborieau, Marianne, Huynh, Vien The, de Souza, Paul L., Stenzel, Martina H.
Published in Polymer (Guilford) (13.12.2011)
Published in Polymer (Guilford) (13.12.2011)
Get full text
Journal Article
Role of the Akt pathway in prostate cancer
de Souza, Paul L, Russell, Pamela J, Kearsley, John
Published in Current cancer drug targets (01.03.2009)
Published in Current cancer drug targets (01.03.2009)
Get more information
Journal Article
Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol™), a novel isoflav-3-ene, in patients with advanced cancer
DE SOUZA, Paul L, LIAUW, Winston, LINKS, Matthew, PIRABHAHAR, Saiyini, KELLY, Graham, HOWES, Laurence G
Published in Cancer chemotherapy and pharmacology (01.10.2006)
Published in Cancer chemotherapy and pharmacology (01.10.2006)
Get full text
Journal Article
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C
METHAROM, Ekkaphon, GALETTIS, Peter, MANNERS, Susan, JELINEK, Maria, LIAUW, Winston, de SOUZA, Paul L, HOSKINS, Janelle M, LINKS, Matthew
Published in Asia-Pacific journal of clinical oncology (01.03.2011)
Published in Asia-Pacific journal of clinical oncology (01.03.2011)
Get full text
Journal Article
Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer
de Souza, Paul L., Capp, Anne Louise, Chikhladze, Nana, Mezvrishvili, Zaza, Messina, Marinella, Mautner, Gisela
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Trial in progress: A phase 1-2, first-in-human, open label, dose escalation and expansion study of AU-007, a monoclonal antibody that binds to IL-2 and inhibits IL-2Rα binding, in patients with advanced solid tumors
Vasselli, James Robert, Frentzas, Sophia, Weickhardt, Andrew James, de Souza, Paul L., Tang, Jenny, Wyant, Tim, Amit, Inbar, Ofran, Yanay, Knickerbocker, Aron
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase I/II trial of NOX66 in combination with nivolumab in patients (pts) with advanced cancer
de Souza, Paul L., Gao, Bo, Marx, Gavin M., Cooper, Adam James, Wilkinson, Kate Jessica, McPherson, Luke, Erskine, Amy, Nixdorf, Sheri, Putterill, Leigh, Mann, Timothy, Sajinovic, Mila, Fatima, Shadma, Scott, Kieran
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A phase 1/2 study of AU-007, a monoclonal antibody (mAb) that binds to IL-2 and inhibits CD25 binding, in patients with advanced solid tumors: Interim results
Frentzas, Sophia, Ahern, Elizabeth Stephanie, Weickhardt, Andrew James, Haydon, Andrew Mark, de Souza, Paul L., Powderly, John D., Wyant, Timothy, Tang, Jenny, Richards, Lori, Knickerbocker, Aron, Amit, Inbar, Ofran, Yanay, Vasselli, James Robert
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article